domperidone has been researched along with epidermal growth factor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dittmar, T; Gnoth, SA; Keil, S; Niggemann, B; Rommerswinkel, N; Stricker, HM | 1 |
1 other study(ies) available for domperidone and epidermal growth factor
Article | Year |
---|---|
The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cells.
Topics: Breast Neoplasms; Calcium; Calcium Signaling; Cell Line, Tumor; Cell Movement; Domperidone; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Female; Humans; Indoles; Phospholipase D; Phosphorylation; Receptors, sigma; RNA, Small Interfering; Sigma-1 Receptor | 2021 |